Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00371150 · ClinicalTrials.gov registry record · Phase 4
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection
A Phase 4 study of Hepatitis B Infection, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 4
- Development phase
- 131
- Enrollment target
- 20
- Study locations
NCT00371150 is a Phase 4 study of Hepatitis B Infection that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 131 participants. The trial reports 20 study locations across 16 states.
The verdict
NCT00371150, a Phase 4 study of Hepatitis B Infection, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 131 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this clinical research study is to develop observational clinical experience with the use of entecavir in participants who are either of Black/African-American race or of Hispanic ethnicity.
Conditions Studied
Interventions
- DRUG Entecavir
Study Locations (20)
Florida
- University Of Miami - Miami
- Empire International Research - Miami
Massachusetts
- Brigham And Women'S Hospital - Boston
- L L C Bda The Research Institute - Springfield
New York
- Va New York Harbor Healthcare System - New York
- Westchester Digestive Disease Group, Llp - Yonkers
São Paulo
- Local Institution - Campinas
- Local Institution - Sao Paulo - Sp
Alabama
- Alabama Liver & Digestive Specialists (Alds) - Montgomery
Arizona
- University Of Arizona - Tucson
District of Columbia
- George Washington University Medical Center - Washington D.C.
Illinois
- University Of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2006-11 |
| Est. Completion | 2011-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00371150
The ClinicalTrials.gov registry entry for NCT00371150 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hepatitis B Infection appearing as the primary indexed condition, and to 1 intervention - of which Entecavir is the first listed.
NCT00371150 reports 20 study locations spanning 16 distinct geographic areas - top geographies include Florida, Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT00371150 about?
NCT00371150 is a clinical study titled "Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection". The purpose of this clinical research study is to develop observational clinical experience with the use of entecavir in participants who are either of Black/African-American race or of Hispanic ethnicity.
What is the current status of trial NCT00371150?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 131 participants. The study started on 2006-11. Estimated completion is 2011-03.
What conditions does trial NCT00371150 study?
This clinical trial studies the following conditions: Hepatitis B Infection.
What interventions are being tested in trial NCT00371150?
The interventions under investigation include: Entecavir (DRUG).
Who is sponsoring clinical trial NCT00371150?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00371150 being conducted?
This trial has 20 study locations across Alabama, Arizona, District of Columbia, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis B Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.